Stanozolol 10 - Androlex

Stanozolol emerged as a clinical tool in 1962 under the name Winstrol, following its synthesis by Winthrop Laboratories. Intended for patients with severe muscle loss, delayed growth, and bone-related conditions, it offered a rare combination of oral activity and non-estrogenic behavior. Its structure, derived from DHT with a pyrazole substitution, allowed it to function without causing water retention. Although U.S. manufacturing ceased, its production continues in countries with established veterinary steroid protocols, where it is especially valued in equine therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 10 by Androlex, consult with your doctor or healthcare professional.